Shinpoong Pharmaceutical Co Ltd (019170) Stock Price & News

019170:KRX

Shinpoong Pharmaceutical Co Ltd

₩9,130.00

-2.87%

(-270.00) 1D

Jun 5, 3:30:29 PM GMT+9 · KRW

All symbols

YTD

MAX

	Symbol	Price	Change	% Change

Generating top insights for 019170...

Open

₩9,290

High

₩9,330

Low

₩9,080

Mkt. cap

506.33B

Avg. vol.

323.62K

Volume

90.32K

P/E ratio

47.29

52-wk high

₩20,500

52-wk low

₩9,080

EPS

₩193

Shares outstanding

52.42M

No. of employees

809

Open

₩9,290

High

₩9,330

Low

₩9,080

Mkt. cap

506.33B

Avg. vol.

323.62K

Volume

90.32K

P/E ratio

47.29

52-wk high

₩20,500

52-wk low

₩9,080

EPS

₩193

Shares outstanding

52.42M

No. of employees

809

Related stocks

iNtRON Biotechnology Inc

News stories

From sources across the web

Yahoo Finance

29 minutes ago

Marvell Technology (MRVL) Is Up 28.5% After AI Switch Launch And S&P 500 Entry - Has The Bull Case Changed?

Seeking Alpha

37 minutes ago

Goldman Sachs: Signs of market exuberance are rising, but fall short of prior bubbles (SP500:)

Crypto Briefing

1 hour ago

S&P 500 sheds $1.8T as Nasdaq records its biggest single-day point drop ever

CNN

1 day ago

Nasdaq, S&P 500 suffer worst day of year as AI stocks tumble and Fed rate-hike odds rise | CNN Business

About Shinpoong Pharmaceutical Co Ltd

CEOYoo Je-man

Employees809

Founded1962

Headquarters-

SectorPharmaceutical industry

Websiteshinpoong.co.kr

All values in KRW	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Revenue	58.62B	62.61B	58.04B	54.53B
Cost of goods sold	31.33B	33.91B	33.04B	33.12B
Cost of revenue	31.33B	33.91B	33.04B	33.12B
Research and development expenses	2.50B	2.39B	1.77B	4.19B
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	19.83B	18.41B	19.16B	18.01B
Operating expense	22.36B	21.48B	21.14B	21.77B
Total operating expenses	53.68B	55.39B	54.17B	54.89B
Operating income	4.94B	7.22B	3.87B	-363.22M
Other non operating income	31.61M	37.58M	56.74M	-42.52M
EBT including unusual items	2.35B	7.26B	302.61M	439.87M
EBT excluding unusual items	2.32B	7.26B	3.25B	423.63M
Income tax expense	-434.02M	847.52M	-147.88M	70.67M
Effective tax rate	-18.48%	11.67%	-48.87%	16.07%
Other operating expenses	183.68M	43.68M	-434.64M	105.86M
Net income	3.27B	6.38B	461.37M	358.51M
Net profit margin	5.58%	10.19%	0.79%	0.66%
Earnings per share	-	-	-	-
Interest and investment income	191.58M	208.75M	200.34M	246.20M
Interest expense	-656.08M	-642.57M	-671.63M	-862.72M
Net interest expenses	-464.50M	-433.82M	-471.28M	-616.52M
Depreciation and amortization charges	354.46M	528.97M	372.83M	362.48M
EBITDA	7.73B	10.17B	6.67B	2.42B
Gain or loss from assets sale	-702.00K	-19.00K	-1.82M	-12.35M

AI content may include mistakes. Learn more

HelpSend feedbackPrivacy Terms Disclaimer

Finance

Research